Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.

Literature DB >> 21803186

Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.

Ioannis Ilias¹, Chaitanya Divgi, Karel Pacak.

Abstract

Despite early reports of excellent diagnostic characteristics of [(131)I]/[(123)I]-metaiodobenzylguanidine (MIBG) in the evaluation of pheochromocytomas/paragangliomas (PHEOs/PGLs) or medullary thyroid cancer as experience with it was accumulated, the sensitivity dropped. Nevertheless, this modality is still useful in the diagnostic work-up of PHEOs/PGLs because it is widely available, and in case of positive scans it might indicate patients who are potential candidates for [(131)I]MIBG therapy. Published by Elsevier Inc.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
3-Iodobenzylguanidine

Year: 2011 PMID： 21803186 PMCID： PMC3415306 DOI： 10.1053/j.semnuclmed.2011.03.003

Source DB: PubMed Journal: Semin Nucl Med ISSN： 0001-2998 Impact factor: 4.446

38 in total

1. Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT.

Authors: J T Nielsen; B V Nielsen; M Rehling
Journal: Clin Nucl Med Date: 1996-09 Impact factor: 7.794

2. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis.

Authors: Anouk N A Van Der Horst-Schrivers; Pieter L Jager; H Marike Boezen; Jan P Schouten; Ido P Kema; Thera P Links
Journal: Anticancer Res Date: 2006 Mar-Apr Impact factor: 2.480

Review 3. Clinical review: Current treatment of malignant pheochromocytoma.

Authors: Tim Scholz; Graeme Eisenhofer; Karel Pacak; Henning Dralle; Hendrik Lehnert
Journal: J Clin Endocrinol Metab Date: 2007-02-06 Impact factor: 5.958

4. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.

Authors: Francesco Giammarile; Arturo Chiti; Michael Lassmann; Boudewijn Brans; Glenn Flux
Journal: Eur J Nucl Med Mol Imaging Date: 2008-05 Impact factor: 9.236

Review 5. Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma.

Authors: Vittoria Rufini; Paola Castaldi; Giorgio Treglia; Germano Perotti; Milton D Gross; Adil Al-Nahhas; Domenico Rubello
Journal: Biomed Pharmacother Date: 2007-08-20 Impact factor: 6.529

Review 6. A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.

Authors: Ioannis Ilias; Karel Pacak
Journal: Nucl Med Biol Date: 2008-08 Impact factor: 2.408

7. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.

Authors: Klaas Pieter Koopmans; Pieter L Jager; Ido P Kema; Michiel N Kerstens; Frans Albers; Robin P F Dullaart
Journal: J Nucl Med Date: 2008-07-16 Impact factor: 10.057

8. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.

Authors: Henri J L M Timmers; Anna Kozupa; Clara C Chen; Jorge A Carrasquillo; Alexander Ling; Graeme Eisenhofer; Karen T Adams; Daniel Solis; Jacques W M Lenders; Karel Pacak
Journal: J Clin Oncol Date: 2007-06-01 Impact factor: 44.544

9. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.

Authors: Kunwar S S Bhatia; Mohamed M Ismail; Anju Sahdev; Andrea G Rockall; Kieran Hogarth; Ana Canizales; Norbert Avril; John P Monson; Ashley B Grossman; Rodney H Reznek
Journal: Clin Endocrinol (Oxf) Date: 2008-04-03 Impact factor: 3.478

Review 10. Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment.

Authors: Elizabeth A Mittendorf; Douglas B Evans; Jeffrey E Lee; Nancy D Perrier
Journal: Hematol Oncol Clin North Am Date: 2007-06 Impact factor: 3.722

15 in total

1. Outcome of Treatment for Medullary Thyroid Carcinoma-a Single Centre Experience.

Authors: Anish Jacob Cherian; Pooja Ramakant; Rekha Pai; Marie Therese Manipadam; S Elanthenral; Anuradha Chandramohan; Julie Hephzibah; David Mathew; Dhukabandhu Naik; Thomas V Paul; Simon Rajaratnam; Nihal Thomas; M J Paul; Deepak Thomas Abraham
Journal: Indian J Surg Oncol Date: 2017-12-08

2. Diagnostic Performance of (68)Ga-DOTATATE PET/CT, (18)F-FDG PET/CT and (131)I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma.

Authors: Teik Hin Tan; Zanariah Hussein; Fathinul Fikri Ahmad Saad; Ibrahim Lutfi Shuaib
Journal: Nucl Med Mol Imaging Date: 2015-04-08

Review 3. Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives.

Authors: Michele Klain; Julien Hadoux; Carmela Nappi; Monica Finessi; Raffaele Ambrosio; Martin Schlumberger; Alberto Cuocolo; Désirée Deandreis; Domenico Salvatore
Journal: Endocrine Date: 2021-11-08 Impact factor: 3.633

4. Inhibitory Effect of the Noncamptothecin Topoisomerase I Inhibitor LMP-400 on Female Mice Models and Human Pheochromocytoma Cells.

Authors: Jan Schovanek; Petra Bullova; Yasin Tayem; Alessio Giubellino; Robert Wesley; Nikoletta Lendvai; Svenja Nölting; Juraj Kopacek; Zdenek Frysak; Yves Pommier; Shivaani Kummar; Karel Pacak
Journal: Endocrinology Date: 2015-08-12 Impact factor: 4.736

5. Retroperitoneal paraganglioma: a chameleon masquerading as an adrenal pheochromocytoma.

Authors: K Parmar; A Chandna; S Kumar
Journal: Ann R Coll Surg Engl Date: 2018-10-29 Impact factor: 1.891

Review 6. Current Consensus on I-131 MIBG Therapy.

Authors: Daiki Kayano; Seigo Kinuya
Journal: Nucl Med Mol Imaging Date: 2018-05-03

7. Incidental Detection of Synchronous Medullary Thyroid Carcinoma with Bilateral Adrenal Pheochromocytoma on Iodine-123 Metaiodobenzylguanidine Scintigraphy, Leading to Diagnosis of Multiple Endocrine Neoplasia 2A.

Authors: Asif Ali Fakhri; Paul David Rodrigue; Mustafa Aladin; Aun Hussain
Journal: World J Nucl Med Date: 2017 Apr-Jun

Review 8. Neuroendocrine tumours of the head and neck: anatomical, functional and molecular imaging and contemporary management.

Authors: Navaraj Subedi; Robin Prestwich; Fahmid Chowdhury; Chirag Patel; Andrew Scarsbrook
Journal: Cancer Imaging Date: 2013-10-04 Impact factor: 3.909

Review 9. Functional Imaging of Paragangliomas with an Emphasis on Von Hippel-Lindau-Associated Disease: A Mini Review.

Authors: Ioannis Ilias; Georgios Meristoudis
Journal: J Kidney Cancer VHL Date: 2017-09-04

10. Catastrophic catecholamine-induced cardiomyopathy rescued by extracorporeal membrane oxygenation in recurrent malignant pheochromocytoma.

Authors: Daniel Min
Journal: Yeungnam Univ J Med Date: 2019-05-22